Associate Professor Michael Barnett

Associate Professor
Medicine, Central Clinical School

Telephone +61 2 9351 0730
Fax +61 2 9351 0653

Map

Selected grants

2014

  • Mapping the immunopeptidome of AQP4 antibody-negative neuromyelitis optica.; Crossett B, Barnett M; Multiple Sclerosis Research Australia/Incubator Grant.
  • A novel assessment of body temperature regulation in MS patients performing physical activity in the heat; Jay O, Barnett M, Hoang P, Davis S, Cobley S; Multiple Sclerosis Research Australia/Incubator Grant.
  • Grant to fund MS Neuropathology and Neuroimaging facilities at the BMRI; Barnett M; Biogen Idec Australia Pty Ltd/Research Grant.
  • Infrastructure Grant to conduct MR imaging on brains donated in NSW; Barnett M; Novartis Pharmaceuticals Australia Pty Limited/Infrastructure Grant.

2013

  • NSW State Reference Laboratory for Nerve and Muscle Pathology; Barnett M; bioCSL Pty Ltd/Research.
  • Tablet-based Data capture in MUltiple Sclerosis (TADIMUS); Barnett M; Novartis Pharmaceuticals Australia Pty Limited/Research Support.
  • Funding for Part-time Structured Neuroradiology Fellowship; Pollard J, Barnett M; Biogen Idec Australia Pty Ltd/Research Support.
  • MSRA Brain Bank; Buckland M, Barnett M; Multiple Sclerosis Research Australia/Research Support.

2012

  • The choroid plexus: a key immunological player?; Barnett M; Merck Serono Australia Pty Ltd/Project Grants.

2011

  • Novel regenerative pathways in multiple sclerosis: a proteomic and in-situ analysis of human tissue; Barnett M; Office for Science and Medical Research (NSW)/Paul Brock Fellowship.
  • Latency delay of multifocal Visual Evoked Potential � true measure of inflammatory demyelination?; Klistorner A, Yiannikas C, Garrick R, Paine M, Barnett M, Masters L, Nguyen T, Graham S; Multiple Sclerosis Research Australia/Investigator Project Grants.

2009

  • Proteomic and in-situ analysis of multiple sclerosis-specific tissue alterations; Barnett M, Prineas J, Crossett B; Multiple Sclerosis Research Australia/Investigator Project Grants.
  • Neurology Research; Barnett M; Novartis Pharmaceuticals Australia Pty Limited/Research Support.

2008

  • Establishing an Australian Multiple Sclerosis Brain Bank; Buckland M, Barnett M; Multiple Sclerosis Research Australia/Investigator Project Grants.
  • Multiple Sclerosis Unencumbered Research; Barnett M; Merck Serono Australia Pty Ltd/Research Support.

2002

  • Multi Sclerosis Fellow - Barnett; Barnett M; Neuro Foundation/Fellowship.
  • Research in to Inflammatory Neuropathies / Sutton; Barnett M; Biogen Idec Australia Pty Ltd/Research Support.

Selected publications

Download citations: PDF RTF Endnote

Journals

  • Klistorner, A., Sriram, P., Vootakuru, N., Wang, C., Barnett, M., Garrick, R., Parratt, J., Levin, N., Raz, N., van der Walt, A., Masters, L., et al (2014). Axonal loss of retinal neurons in multiple sclerosis associated with optic radiation lesions. Neurology, 82(24), 2165-2172. [More Information]
  • Barnett, Y., Sutton, I., Ghadiri, M., Masters, L., Zivadinov, R., Barnett, M. (2014). Conventional and Advanced Imaging in Neuromyelitis Optica. American Journal Of Neuroradiology, 35(8), 1458-1466. [More Information]
  • Jokubaitis, V., Li, V., Kalincik, T., Izquierdo, G., Hodgkinson, S., Alroughani, R., Lechner-Scott, J., Lugaresi, A., Duquette, P., Girard, M., Barnett, M., et al (2014). Fingolimod after natalizumab and the risk of short-term relapse. Neurology, 82(14), 1204-1211. [More Information]
  • Alshowaeir, D., Yiannikas, C., Garrick, R., Parratt, J., Barnett, M., Graham, S., Klistorner, A. (2014). Latency of multifocal Visual Evoked Potentials in non-optic neuritis eyes of multiple sclerosis patients associated with optic radiation lesions. Investigative Ophthalmology & Visual Science, 55(6), 3758-3764. [More Information]
  • Hughes, S., Spelman, T., Gray, O., Boz, C., Trojano, M., Lugaresi, A., Izquierdo, G., Duquette, P., Girard, M., GrandMaison, F., Barnett, M., Vucic, S., et al (2014). Predictors and dynamics of postpartum relapses in women with multiple sclerosis. Multiple Sclerosis Journal, 20(6), 739-746. [More Information]
  • Ghadiri, M., Buckland, M., Sutton, I., Al Jahdhami, S., Flanagan, S., Heard, R., Barnett, Y., Brennan, J., Barnett, M. (2014). Progressive Neuropsychiatric Symptoms and Motor Impairment. JAMA Neurology, 71(6), 794-798. [More Information]
  • Parnell, G., Gatt, P., Krupa, M., Dorothee, N., McKay, F., Schibeci, S., Batten, M., Baranzini, S., Henderson, A., Barnett, M., Vucic, S., Stewart, G., Booth, D., et al (2014). The autoimmune disease-associated transcription factors EOMES and TBX21 are dysregulated in multiple sclerosis and define a molecular subtype of disease. Clinical Immunology, 151(1), 16-24. [More Information]
  • Broadley, S., Barnett, M., Boggild, M., Brew, B., Butzkueven, H., Heard, R., Hodgkinson, S., Kermode, A., Lechner-Scott, J., Lechner-Scott, J., Parratt, J., Reddel, S., Spies, J., Pollard, J., et al (2014). Therapeutic approaches to disease modifying therapy for multiple sclerosis in adults: An Australian and New Zealand perspective Part 1 Historical and established therapies. Journal of Clinical Neuroscience, 21(11), 1835-1846. [More Information]
  • Broadley, S., Barnett, M., Boggild, M., Brew, B., Butzkueven, H., Heard, R., Hodgkinson, S., Kermode, A., Lechner-Scott, J., Macdonell, R., Parratt, J., Reddel, S., Spies, J., Pollard, J., et al (2014). Therapeutic approaches to disease modifying therapy for multiple sclerosis in adults: An Australian and New Zealand perspective Part 2 New and emerging therapies and their efficacy. Journal of Clinical Neuroscience, 21(11), 1847-1856. [More Information]
  • Broadley, S., Barnett, M., Boggild, M., Brew, B., Butzkueven, H., Heard, R., Hodgkinson, S., Kermode, A., Lechner-Scott, J., Macdonell, R., Parratt, J., Reddel, S., Spies, J., Pollard, J., et al (2014). Therapeutic approaches to disease modifying therapy for multiple sclerosis in adults: An Australian and New Zealand perspective Part 3 Treatment practicalities and recommendations. Journal of Clinical Neuroscience, 21(11), 1857-1865. [More Information]
  • Klistorner, A., Garrick, R., Barnett, M., Graham, S., Arvind Srinivasan, H., Sriram, P., Yiannikas, C. (2013). Axonal loss in non-optic neuritis eyes of patients with multiple sclerosis linked to delayed visual evoked potential. Neurology, 80(3), 242-245. [More Information]
  • Verheul, F., Smolders, J., Trojano, M., Lepore, V., Zwanikken, C., Amato, M., Grand'Maison, F., Butzkueven, H., Marrosu, M., Duquette, P., Barnett, M., et al (2013). Fluctuations of MS births and UV-light exposure. Acta Neurologica Scandinavica, 127(5), 301-308. [More Information]
  • Lin, R., Charlesworth, J., Stankovich, J., Perreau, V., Brown, M., Taylor, B., Baxter, A., Kermode, A., Bahlo, M., Booth, D., Stewart, G., Barnett, M., Heard, R., et al (2013). Identity-by-Descent Mapping to Detect Rare Variants Conferring Susceptibility to Multiple Sclerosis. PloS One, 8(3), 1-8. [More Information]
  • Kaushik, M., Wang, C., Barnett, M., Garrick, R., Parratt, J., Graham, S., Sriram, P., Yiannikas, C., Klistorner, A. (2013). Inner Nuclear Layer Thickening Is Inversley Proportional to Retinal Ganglion Cell Loss in Optic Neuritis. PloS One, 8(10), 1-8. [More Information]
  • Kalinick, T., Spelman, T., Trojano, M., Duquette, P., Izquierdo, G., Grammond, P., Lugaresi, A., Hupperts, R., Cristiano, E., Van Pesch, V., Barnett, M., Vucic, S., et al (2013). Persistence on Therapy and Propensity Matched Outcome Comparison of Two Subcutaneous Interferon Beta 1a Dosages for Multiple Sclerosis. PloS One, 8(5), 1-9. [More Information]
  • Barnett, M., Hardy, T., Garsia, R., Halmagyi, G., Lewis, S., Harrisberg, B., Fulham, M. (2013). Response to Letter to the Editor: Susac's syndrome. Journal of the Neurological Sciences, 314(1-2), 183-183. [More Information]
  • Kalincik, T., Vivek, V., Jokubaitis, V., Lechner-Scott, J., Trojano, M., Izquierdo, G., Lugaresi, A., Grand'Maison, F., Hupperts, R., Oreja-Guevara, C., Vucic, S., Barnett, M., et al (2013). Sex as a determinant of relapse incidence and progressive course of multiple sclerosis. Brain, 136(12), 3609-3617. [More Information]
  • Jokubaitis, V., Spelman, T., Lechner-Scott, J., Barnett, M., Shaw, C., Vucic, S., Liew, D., Butzkueven, H., Slee, M. (2013). The Australian Multiple Sclerosis (MS) immunotherapy study: a prospective, multicentre study of drug utilisation using the MSBase platform. PloS One, 8(3), 1-9. [More Information]
  • Minagar, A., Barnett, M., Benedict, R., Pelletier, D., Pirko, I., Sahraian, M., Frohman, E., Zivadinov, R. (2013). The thalamus and multiple sclerosis: Modern views on pathologic, imaging, and clinical aspects. Neurology, 80(2), 210-219. [More Information]
  • Meyniel, C., Spelman, T., Jokubaitis, V., Trojano, M., Izquierdo, G., Grand'Maison, F., Oreja-Guevara, C., Boz, C., Lugaresi, A., Girard, M., Barnett, M., et al (2012). Country, Sex, EDSS Change and Therapy Choice Independently Predict Treatment Discontinuation in Multiple Sclerosis and Clinically Isolated Syndrome. PloS One, 7(6), 1-8. [More Information]
  • Simon, N., Parratt, J., Barnett, M., Buckland, M., Gupta, R., Hayes, M., Masters, L., Reddel, S. (2012). Expanding the clinical, radiological and neuropathological phenotype of chronic lymphocytic inflammation with pontine perivascular enhancement responsive to steroids (CLIPPERS). Journal of Neurology, Neurosurgery, and Psychiatry, 83(1), 15-22. [More Information]
  • Bien, C., Vincent, A., Barnett, M., Becker, A., Blumcke, I., Graus, F., Jellinger, K., Reuss, D., Ribalta, T., Schlegel, J., et al (2012). Immunopathology of autoantibody-associated encephalitides: clues for pathogenesis. Brain: a journal of neurology, 135(Pt 5), 1622-1638. [More Information]
  • Chohan, G., Barnett, Y., Gibson, J., Reddel, S., Barnett, M. (2012). Langerhans cell histiocytosis with refractory central nervous system involvement responsive to infliximab. Journal of Neurology, Neurosurgery, and Psychiatry, 83(5), 573-575. [More Information]
  • Barnett, M., Prineas, J., Buckland, M., Parratt, J., Pollard, J. (2012). Massive astrocyte destruction in neuromyelitis optica despite natalizumab therapy. Multiple Sclerosis Journal, 18(1), 108-112. [More Information]
  • Bukhari, W., Barnett, M., Prain, K., Broadley, S. (2012). Molecular Pathogenesis of Neuromyelitis Optica. International Journal of Molecular Sciences, 13(10), 12970-12993. [More Information]
  • Barnett, M., Sutton, I. (2012). Neuromyelitis optica: not a multiple sclerosis variant. Current Opinion In Neurology, 25(3), 215-220. [More Information]
  • Hurelbrink, C., Barnett, Y., Buckland, M., Wilkinson, M., Leicester, J., Anderson, C., Brennan, J., Barnett, M. (2012). Revisiting cerebral thromboangiitis obliterans. Journal of the Neurological Sciences, 317(1-2), 141-145. [More Information]
  • Hardy, T., Barnett, M., Mohamed, A., Garsia, R., Davies, L. (2012). Severe Bickerstaffs encephalitis treated with Rituximab: Serum and CSF GQ1b antibodies. Journal of Neuroimmunology, 251(1/2), 107-109. [More Information]
  • Disanto, G., Morahan, J., Barnett, M., Giovannoni, G., Ramagopalan, S. (2012). The evidence for a role of B cells in multiple sclerosis. Neurology, 78(11), 823-832. [More Information]
  • Lechner-Scott, J., Spencer, B., de Malmanche, T., Attia, J., Fitzgerald, M., Trojano, M., Francois, G., Gomez, J., Izquierdo, G., Duquette, P., Barnett, M., et al (2012). The frequency of CSF oligoclonal banding in multiple sclerosis increases with latitude. Multiple Sclerosis Journal, 18(7), 974-982. [More Information]
  • Hughes, S., Spelman, T., Trojano, M., Lugaresi, A., Izquierdo, G., Grand'Maison, F., Duquette, P., Girard, M., Grammond, P., Oreja-Guevara, C., Barnett, M., et al (2012). The Kurtzke EDSS rank stability increases 4 years after the onset of multiple sclerosis: results from the MSBase Registry. Journal of Neurology, Neurosurgery and Psychiatry, 83(3), 305-310. [More Information]
  • Barnett, M., Chohan, G., Davies, L. (2011). Blurred vision and pain in the eye. Medical Journal of Australia, 195(6), 329-332. [More Information]
  • Ly, L., Barnett, M., Zheng, Y., Gulati, T., Prineas, J., Crossett, B. (2011). Comprehensive Tissue Processing Strategy for Quantitative Proteomics of Formalin-fixed Multiple Sclerosis Lesions. Journal of Proteome Research, 10(10), 4855-4868. [More Information]
  • Ahmed, R., Buckland, M., Davies, L., Halmagyi, G., Rogers, S., Oberste, M., Barnett, M. (2011). Enterovirus 71 meningoencephalitis complicating rituximab therapy. Journal of the Neurological Sciences, 305(1-2), 149-151. [More Information]
  • Barnett, M., Barnett, Y., Burke, D., Willison, H. (2011). Spinal nerve root hypertrophy in chronic ataxic neuropathy with antiglycolipid IgM antibodies. Journal of Neurology, Neurosurgery and Psychiatry, 82(1), 97. [More Information]
  • Hardy, T., Garsia, R., Halmagyi, G., Lewis, S., Harrisberg, B., Fulham, M., Barnett, M. (2011). Tumour necrosis factor (TNF) inhibitor therapy in Susac's syndrome. Journal of the Neurological Sciences, 302(1-2), 126-128. [More Information]
  • Henderson, A., Barnett, M., Parratt, J. (2010). Reply. Annals of Neurology, 68(5), 768. [More Information]
  • Sutton, I., Lahoria, R., Tan, I., Clouston, P., Barnett, M. (2009). CNS demyelination and quadrivalent HPV vaccination. Multiple Sclerosis: clinical and laboratory research, 15(1), 116-119. [More Information]
  • Barnett, M., Parratt, J., Cho, E., Prineas, J. (2009). Immunoglobulins and complement in postmortem multiple sclerosis tissue. Annals of Neurology, 65(1), 32-46. [More Information]
  • Barnett, M., Parratt, J., Pollard, J., Prineas, J. (2009). MS: Is it One Disease? The International M S Journal, 16(2), 57-65. [More Information]
  • Henderson, A., Barnett, M., Parratt, J., Prineas, J. (2009). Multiple sclerosis: Distribution of inflammatory cells in newly forming lesions. Annals of Neurology, 66(6), 739-753. [More Information]
  • Granot, R., Lawrence, R., Barnett, M., Masters, L., Rodriguez, M., Theocharous, C., Pamphlett, R., Hersch, M. (2009). What lies beneath the tent? JC-virus cerebellar granule cell neuronopathy complicating sarcoidosis. Journal of Clinical Neuroscience, 16(8), 1091-2. [More Information]
  • McLeod, J., Barnett, M., Macaskill, P., Williams, D. (2007). Long-term prognosis of multiple sclerosis in Australia. Journal of the Neurological Sciences, 256, 35-38. [More Information]
  • Barnett, M., Henderson, A., Prineas, J. (2006). The macrophage in MS: just a scavenger after all? Pathology and pathogenesis of the acute MS lesion. Multiple Sclerosis: clinical and laboratory research, 12(2), 121-132. [More Information]
  • Barnett, M., Sutton, I. (2006). The pathology of multiple sclerosis: a paradigm shift. Current Opinion In Neurology, 19(3), 242-247. [More Information]
  • Barnett, M., Prineas, J. (2004). Relapsing And Remitting Multiple Sclerosis: Pathology Of The Newly Forming Lesion. Annals of Neurology, 55(4), 458-468. [More Information]
  • Barnett, M., Williams, D., Day, S., Macaskill, P., McLeod, J. (2003). Progressive increase in incidence and prevalence of multiple sclerosis in Newcastle, Australia: a 35-year study. Journal of the Neurological Sciences, 213(1-2), 1-6.
  • Iland, H., Barnett, M., Pollard, J., Supple, S. (2001). A spontaneous novel XK gene mutation in a patient with McLeod syndrome. British Journal of Haematology, 115, 369-372.

Conferences

  • Patani, (., Barnett, M., Prineas, J. (2006). The pathology of impaired remyelination in multiple sclerosis. 189th Meeting of the Pathological Society of Great Britain and Ireland, United Kingdom: John Wiley & Sons.

2014

  • Klistorner, A., Sriram, P., Vootakuru, N., Wang, C., Barnett, M., Garrick, R., Parratt, J., Levin, N., Raz, N., van der Walt, A., Masters, L., et al (2014). Axonal loss of retinal neurons in multiple sclerosis associated with optic radiation lesions. Neurology, 82(24), 2165-2172. [More Information]
  • Barnett, Y., Sutton, I., Ghadiri, M., Masters, L., Zivadinov, R., Barnett, M. (2014). Conventional and Advanced Imaging in Neuromyelitis Optica. American Journal Of Neuroradiology, 35(8), 1458-1466. [More Information]
  • Jokubaitis, V., Li, V., Kalincik, T., Izquierdo, G., Hodgkinson, S., Alroughani, R., Lechner-Scott, J., Lugaresi, A., Duquette, P., Girard, M., Barnett, M., et al (2014). Fingolimod after natalizumab and the risk of short-term relapse. Neurology, 82(14), 1204-1211. [More Information]
  • Alshowaeir, D., Yiannikas, C., Garrick, R., Parratt, J., Barnett, M., Graham, S., Klistorner, A. (2014). Latency of multifocal Visual Evoked Potentials in non-optic neuritis eyes of multiple sclerosis patients associated with optic radiation lesions. Investigative Ophthalmology & Visual Science, 55(6), 3758-3764. [More Information]
  • Hughes, S., Spelman, T., Gray, O., Boz, C., Trojano, M., Lugaresi, A., Izquierdo, G., Duquette, P., Girard, M., GrandMaison, F., Barnett, M., Vucic, S., et al (2014). Predictors and dynamics of postpartum relapses in women with multiple sclerosis. Multiple Sclerosis Journal, 20(6), 739-746. [More Information]
  • Ghadiri, M., Buckland, M., Sutton, I., Al Jahdhami, S., Flanagan, S., Heard, R., Barnett, Y., Brennan, J., Barnett, M. (2014). Progressive Neuropsychiatric Symptoms and Motor Impairment. JAMA Neurology, 71(6), 794-798. [More Information]
  • Parnell, G., Gatt, P., Krupa, M., Dorothee, N., McKay, F., Schibeci, S., Batten, M., Baranzini, S., Henderson, A., Barnett, M., Vucic, S., Stewart, G., Booth, D., et al (2014). The autoimmune disease-associated transcription factors EOMES and TBX21 are dysregulated in multiple sclerosis and define a molecular subtype of disease. Clinical Immunology, 151(1), 16-24. [More Information]
  • Broadley, S., Barnett, M., Boggild, M., Brew, B., Butzkueven, H., Heard, R., Hodgkinson, S., Kermode, A., Lechner-Scott, J., Lechner-Scott, J., Parratt, J., Reddel, S., Spies, J., Pollard, J., et al (2014). Therapeutic approaches to disease modifying therapy for multiple sclerosis in adults: An Australian and New Zealand perspective Part 1 Historical and established therapies. Journal of Clinical Neuroscience, 21(11), 1835-1846. [More Information]
  • Broadley, S., Barnett, M., Boggild, M., Brew, B., Butzkueven, H., Heard, R., Hodgkinson, S., Kermode, A., Lechner-Scott, J., Macdonell, R., Parratt, J., Reddel, S., Spies, J., Pollard, J., et al (2014). Therapeutic approaches to disease modifying therapy for multiple sclerosis in adults: An Australian and New Zealand perspective Part 2 New and emerging therapies and their efficacy. Journal of Clinical Neuroscience, 21(11), 1847-1856. [More Information]
  • Broadley, S., Barnett, M., Boggild, M., Brew, B., Butzkueven, H., Heard, R., Hodgkinson, S., Kermode, A., Lechner-Scott, J., Macdonell, R., Parratt, J., Reddel, S., Spies, J., Pollard, J., et al (2014). Therapeutic approaches to disease modifying therapy for multiple sclerosis in adults: An Australian and New Zealand perspective Part 3 Treatment practicalities and recommendations. Journal of Clinical Neuroscience, 21(11), 1857-1865. [More Information]

2013

  • Klistorner, A., Garrick, R., Barnett, M., Graham, S., Arvind Srinivasan, H., Sriram, P., Yiannikas, C. (2013). Axonal loss in non-optic neuritis eyes of patients with multiple sclerosis linked to delayed visual evoked potential. Neurology, 80(3), 242-245. [More Information]
  • Verheul, F., Smolders, J., Trojano, M., Lepore, V., Zwanikken, C., Amato, M., Grand'Maison, F., Butzkueven, H., Marrosu, M., Duquette, P., Barnett, M., et al (2013). Fluctuations of MS births and UV-light exposure. Acta Neurologica Scandinavica, 127(5), 301-308. [More Information]
  • Lin, R., Charlesworth, J., Stankovich, J., Perreau, V., Brown, M., Taylor, B., Baxter, A., Kermode, A., Bahlo, M., Booth, D., Stewart, G., Barnett, M., Heard, R., et al (2013). Identity-by-Descent Mapping to Detect Rare Variants Conferring Susceptibility to Multiple Sclerosis. PloS One, 8(3), 1-8. [More Information]
  • Kaushik, M., Wang, C., Barnett, M., Garrick, R., Parratt, J., Graham, S., Sriram, P., Yiannikas, C., Klistorner, A. (2013). Inner Nuclear Layer Thickening Is Inversley Proportional to Retinal Ganglion Cell Loss in Optic Neuritis. PloS One, 8(10), 1-8. [More Information]
  • Kalinick, T., Spelman, T., Trojano, M., Duquette, P., Izquierdo, G., Grammond, P., Lugaresi, A., Hupperts, R., Cristiano, E., Van Pesch, V., Barnett, M., Vucic, S., et al (2013). Persistence on Therapy and Propensity Matched Outcome Comparison of Two Subcutaneous Interferon Beta 1a Dosages for Multiple Sclerosis. PloS One, 8(5), 1-9. [More Information]
  • Barnett, M., Hardy, T., Garsia, R., Halmagyi, G., Lewis, S., Harrisberg, B., Fulham, M. (2013). Response to Letter to the Editor: Susac's syndrome. Journal of the Neurological Sciences, 314(1-2), 183-183. [More Information]
  • Kalincik, T., Vivek, V., Jokubaitis, V., Lechner-Scott, J., Trojano, M., Izquierdo, G., Lugaresi, A., Grand'Maison, F., Hupperts, R., Oreja-Guevara, C., Vucic, S., Barnett, M., et al (2013). Sex as a determinant of relapse incidence and progressive course of multiple sclerosis. Brain, 136(12), 3609-3617. [More Information]
  • Jokubaitis, V., Spelman, T., Lechner-Scott, J., Barnett, M., Shaw, C., Vucic, S., Liew, D., Butzkueven, H., Slee, M. (2013). The Australian Multiple Sclerosis (MS) immunotherapy study: a prospective, multicentre study of drug utilisation using the MSBase platform. PloS One, 8(3), 1-9. [More Information]
  • Minagar, A., Barnett, M., Benedict, R., Pelletier, D., Pirko, I., Sahraian, M., Frohman, E., Zivadinov, R. (2013). The thalamus and multiple sclerosis: Modern views on pathologic, imaging, and clinical aspects. Neurology, 80(2), 210-219. [More Information]

2012

  • Meyniel, C., Spelman, T., Jokubaitis, V., Trojano, M., Izquierdo, G., Grand'Maison, F., Oreja-Guevara, C., Boz, C., Lugaresi, A., Girard, M., Barnett, M., et al (2012). Country, Sex, EDSS Change and Therapy Choice Independently Predict Treatment Discontinuation in Multiple Sclerosis and Clinically Isolated Syndrome. PloS One, 7(6), 1-8. [More Information]
  • Simon, N., Parratt, J., Barnett, M., Buckland, M., Gupta, R., Hayes, M., Masters, L., Reddel, S. (2012). Expanding the clinical, radiological and neuropathological phenotype of chronic lymphocytic inflammation with pontine perivascular enhancement responsive to steroids (CLIPPERS). Journal of Neurology, Neurosurgery, and Psychiatry, 83(1), 15-22. [More Information]
  • Bien, C., Vincent, A., Barnett, M., Becker, A., Blumcke, I., Graus, F., Jellinger, K., Reuss, D., Ribalta, T., Schlegel, J., et al (2012). Immunopathology of autoantibody-associated encephalitides: clues for pathogenesis. Brain: a journal of neurology, 135(Pt 5), 1622-1638. [More Information]
  • Chohan, G., Barnett, Y., Gibson, J., Reddel, S., Barnett, M. (2012). Langerhans cell histiocytosis with refractory central nervous system involvement responsive to infliximab. Journal of Neurology, Neurosurgery, and Psychiatry, 83(5), 573-575. [More Information]
  • Barnett, M., Prineas, J., Buckland, M., Parratt, J., Pollard, J. (2012). Massive astrocyte destruction in neuromyelitis optica despite natalizumab therapy. Multiple Sclerosis Journal, 18(1), 108-112. [More Information]
  • Bukhari, W., Barnett, M., Prain, K., Broadley, S. (2012). Molecular Pathogenesis of Neuromyelitis Optica. International Journal of Molecular Sciences, 13(10), 12970-12993. [More Information]
  • Barnett, M., Sutton, I. (2012). Neuromyelitis optica: not a multiple sclerosis variant. Current Opinion In Neurology, 25(3), 215-220. [More Information]
  • Hurelbrink, C., Barnett, Y., Buckland, M., Wilkinson, M., Leicester, J., Anderson, C., Brennan, J., Barnett, M. (2012). Revisiting cerebral thromboangiitis obliterans. Journal of the Neurological Sciences, 317(1-2), 141-145. [More Information]
  • Hardy, T., Barnett, M., Mohamed, A., Garsia, R., Davies, L. (2012). Severe Bickerstaffs encephalitis treated with Rituximab: Serum and CSF GQ1b antibodies. Journal of Neuroimmunology, 251(1/2), 107-109. [More Information]
  • Disanto, G., Morahan, J., Barnett, M., Giovannoni, G., Ramagopalan, S. (2012). The evidence for a role of B cells in multiple sclerosis. Neurology, 78(11), 823-832. [More Information]
  • Lechner-Scott, J., Spencer, B., de Malmanche, T., Attia, J., Fitzgerald, M., Trojano, M., Francois, G., Gomez, J., Izquierdo, G., Duquette, P., Barnett, M., et al (2012). The frequency of CSF oligoclonal banding in multiple sclerosis increases with latitude. Multiple Sclerosis Journal, 18(7), 974-982. [More Information]
  • Hughes, S., Spelman, T., Trojano, M., Lugaresi, A., Izquierdo, G., Grand'Maison, F., Duquette, P., Girard, M., Grammond, P., Oreja-Guevara, C., Barnett, M., et al (2012). The Kurtzke EDSS rank stability increases 4 years after the onset of multiple sclerosis: results from the MSBase Registry. Journal of Neurology, Neurosurgery and Psychiatry, 83(3), 305-310. [More Information]

2011

  • Barnett, M., Chohan, G., Davies, L. (2011). Blurred vision and pain in the eye. Medical Journal of Australia, 195(6), 329-332. [More Information]
  • Ly, L., Barnett, M., Zheng, Y., Gulati, T., Prineas, J., Crossett, B. (2011). Comprehensive Tissue Processing Strategy for Quantitative Proteomics of Formalin-fixed Multiple Sclerosis Lesions. Journal of Proteome Research, 10(10), 4855-4868. [More Information]
  • Ahmed, R., Buckland, M., Davies, L., Halmagyi, G., Rogers, S., Oberste, M., Barnett, M. (2011). Enterovirus 71 meningoencephalitis complicating rituximab therapy. Journal of the Neurological Sciences, 305(1-2), 149-151. [More Information]
  • Barnett, M., Barnett, Y., Burke, D., Willison, H. (2011). Spinal nerve root hypertrophy in chronic ataxic neuropathy with antiglycolipid IgM antibodies. Journal of Neurology, Neurosurgery and Psychiatry, 82(1), 97. [More Information]
  • Hardy, T., Garsia, R., Halmagyi, G., Lewis, S., Harrisberg, B., Fulham, M., Barnett, M. (2011). Tumour necrosis factor (TNF) inhibitor therapy in Susac's syndrome. Journal of the Neurological Sciences, 302(1-2), 126-128. [More Information]

2010

  • Henderson, A., Barnett, M., Parratt, J. (2010). Reply. Annals of Neurology, 68(5), 768. [More Information]

2009

  • Sutton, I., Lahoria, R., Tan, I., Clouston, P., Barnett, M. (2009). CNS demyelination and quadrivalent HPV vaccination. Multiple Sclerosis: clinical and laboratory research, 15(1), 116-119. [More Information]
  • Barnett, M., Parratt, J., Cho, E., Prineas, J. (2009). Immunoglobulins and complement in postmortem multiple sclerosis tissue. Annals of Neurology, 65(1), 32-46. [More Information]
  • Barnett, M., Parratt, J., Pollard, J., Prineas, J. (2009). MS: Is it One Disease? The International M S Journal, 16(2), 57-65. [More Information]
  • Henderson, A., Barnett, M., Parratt, J., Prineas, J. (2009). Multiple sclerosis: Distribution of inflammatory cells in newly forming lesions. Annals of Neurology, 66(6), 739-753. [More Information]
  • Granot, R., Lawrence, R., Barnett, M., Masters, L., Rodriguez, M., Theocharous, C., Pamphlett, R., Hersch, M. (2009). What lies beneath the tent? JC-virus cerebellar granule cell neuronopathy complicating sarcoidosis. Journal of Clinical Neuroscience, 16(8), 1091-2. [More Information]

2007

  • McLeod, J., Barnett, M., Macaskill, P., Williams, D. (2007). Long-term prognosis of multiple sclerosis in Australia. Journal of the Neurological Sciences, 256, 35-38. [More Information]

2006

  • Barnett, M., Henderson, A., Prineas, J. (2006). The macrophage in MS: just a scavenger after all? Pathology and pathogenesis of the acute MS lesion. Multiple Sclerosis: clinical and laboratory research, 12(2), 121-132. [More Information]
  • Patani, (., Barnett, M., Prineas, J. (2006). The pathology of impaired remyelination in multiple sclerosis. 189th Meeting of the Pathological Society of Great Britain and Ireland, United Kingdom: John Wiley & Sons.
  • Barnett, M., Sutton, I. (2006). The pathology of multiple sclerosis: a paradigm shift. Current Opinion In Neurology, 19(3), 242-247. [More Information]

2004

  • Barnett, M., Prineas, J. (2004). Relapsing And Remitting Multiple Sclerosis: Pathology Of The Newly Forming Lesion. Annals of Neurology, 55(4), 458-468. [More Information]

2003

  • Barnett, M., Williams, D., Day, S., Macaskill, P., McLeod, J. (2003). Progressive increase in incidence and prevalence of multiple sclerosis in Newcastle, Australia: a 35-year study. Journal of the Neurological Sciences, 213(1-2), 1-6.

2001

  • Iland, H., Barnett, M., Pollard, J., Supple, S. (2001). A spontaneous novel XK gene mutation in a patient with McLeod syndrome. British Journal of Haematology, 115, 369-372.

To update your profile click here. For support on your academic profile contact .